RecallDepth
Class III Terminated

mitoXANTRONE Injection USP (concentrate), 20 mg/10 mL (2 mg/mL), 10 mL Multiple Dose Vial, Rx only, Teva Parenteral Medicines, Inc., Irvine, CA 92618, NDC 0703-4685-01.

Company
Teva Pharmaceuticals Usa
Recall Initiated
September 13, 2016
Posted
October 19, 2016
Recall Number
D-0095-2017
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
11,214 vials
Firm Location
North Wales, PA, United States

Reason for Recall

Failed Impurities/Degradation Specifications: potential failure to meet the specification for Impurity D throughout shelf-life.

Distribution

Nationwide

Lot / Code Info

Lot Numbers: 31318574B, Exp 09/16; 31319610B, Exp 07/17; 31320058B, Exp 11/17; 31320497B, Exp 12/17; 31320744B, Exp 02/18

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class III Drug recalls